Company intelligence
Adalvo
We're driven by our passion for relentless commitment to the partner network we serve.
About Adalvo
Adalvo is a leading global B2B pharmaceutical company, combining a differentiated portfolio with an end-to-end platform that brings complex generics, 505(b)(2) products, peptides, biosimilars and GLP-1s to market quickly and sustains reliable supply over the long term. From portfolio selection through development, regulatory and supply to commercial out-licensing, Adalvo partners with over 170 pharmaceutical companies across more than 140 countries, turning technical capability into repeatable, first-to-market delivery. Headquartered in Malta and backed by EQT, Adalvo is committed to making a difference for patients around the world.
Verified activity
Signals from Adalvo
4 published signals
Presence & Recognition
Adalvo supported Neptunes WPSC securing their 28th league title in the Summer League Final Play-Off 2026 after a commanding victory over Sliema.
Reported by Adalvo
Presence & Recognition
Adalvo is hosting a Happy Hour event at Stand 18A1 throughout CPHI Milan
Reported by Adalvo
Presence & Recognition
Adalvo has been named a finalist in two additional categories at the 2026 CPHI Awards: CEO of the Year for ANIL OKAY and Woman of the Year for Martina Feitzinger.
Reported by Adalvo
Partnerships
Adalvo and LIBBS FARMACÊUTICA LTDA expanded their partnership in Brazil to deepen a strategic partnership focused on bringing high-quality, affordable medicines to patients across Brazil.
Reported by Adalvo